About Valeant

• Key Facts and History
• Board of Directors & Management
• Corporate Governance
• By-laws
• Governance Guidelines
• Committee Structure
• Committee Charters
• Code of Business Conduct & Ethics
• Other Ethics Disclosures
• Sales and Marketing Compliance
• Patient Programs
• Patient Assistance Program
• Unrestricted Education Grants
• Research Grant (PDF)
• Locations
• Contact Us

Products & Pipeline

• Dermatology
• Acanya™
• Atralin™
• Efudex/Efudix®
• Oxsoralen-Ultra®
• Neurology
• DIASTAT® AcuDial™
• Migranal®
• Tasmar®
• Zelapar®
• Consumer Brands
• Kinerase®
• Nyal®
• Bedoyecta®
• CeraVe™
• Dermatix™ Ultra
• Branded Generics
• Development Pipeline
• Dermatology Pipeline
• Neurology Pipeline
• Partnerships

Regional Expertise

• Australia
• Canada
• Europe
• Latin America
• United States

Investor Relations

• Stock Chart
• News Releases
• Financial Reports
• Events & Presentations
• Annual Reports
• Analyst Coverage
• SEC Filings
• Advanced Fundamentals
• Corporate Governance
• Shareholder Services
• Information Request
• E-mail Alerts

Career Opportunities

• Employee Benefits